Information Journal Paper
APA:
CopySHARIFI, S.. (2015). DOXORUBICIN CHANGES BAX /BCL-XL RATIO, CASPASE-8 AND 9 IN BREAST CANCER CELLS. ADVANCED PHARMACEUTICAL BULLETIN, 5(3), 351-359. SID. https://sid.ir/paper/331887/en
Vancouver:
CopySHARIFI S.. DOXORUBICIN CHANGES BAX /BCL-XL RATIO, CASPASE-8 AND 9 IN BREAST CANCER CELLS. ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2015;5(3):351-359. Available from: https://sid.ir/paper/331887/en
IEEE:
CopyS. SHARIFI, “DOXORUBICIN CHANGES BAX /BCL-XL RATIO, CASPASE-8 AND 9 IN BREAST CANCER CELLS,” ADVANCED PHARMACEUTICAL BULLETIN, vol. 5, no. 3, pp. 351–359, 2015, [Online]. Available: https://sid.ir/paper/331887/en